UK – MHRA issues new guidance on the use of life saving adrenaline auto-injectors

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched new guidance to highlight the latest safety advice on the steps to take during anaphylaxis. This new guidance includes an easy step-by-step guide on what to do in an emergency and provides updated advice on body positioning.

Today marks the start of World Allergy Week, an annual initiative led by the World Allergy Organization, aiming to raise awareness of allergies, their management and prevention. With over 20% of the UK’s population affected by at least one allergy, adrenaline auto-injectors (AAIs) are an important healthcare product used for those at risk of anaphylaxis and can save lives.

AAIs in the UK include Epipens or Jext products, and are prescribed for those at risk of anaphylaxis…